Abstract
Todd M. Pryce, Jan Williamson
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Unresolved referenced work
Kept as external metadata until matched
Evaluation of the ResistancePlus MG FleXible assay for detection of wild-type and 23S rRNA-mutated Mycoplasma genitalium strains
10.1128/jcm.01900-19 · 2020
2018 UK national guideline for the management of infection with Neisseria gonorrhoeae
10.1177/0956462419886775 · 2020
Genomic surveillance of Neisseria gonorrhoeae: a crucial tool in the global fight against antimicrobial resistance
10.1080/14787210.2025.2569049 · 2025
Genomic analysis of a Neisseria meningitidis patient isolate causing a false-positive result in the Abbott Alinity m STI, Sweden: a case report
10.1128/asmcr.00143-25 · 2025
False-positive Neisseria gonorrhoeae results on the Abbott Alinity m STI assay caused by Neisseria meningitidis: two cases from Australia
10.1128/jcm.00347-26 · 2026
The past, present and future of molecular testing for Neisseria gonorrhoeae in Australia: still challenging
10.1071/ma24037 · 2024
Second- and third-generation commercial Neisseria gonorrhoeae screening assays and the ongoing issues of false-positive results and confirmatory testing
10.1007/s10096-020-04004-5 · 2021
Maximizing the Neisseria gonorrhoeae confirmatory rate and the genotypic detection of ciprofloxacin resistance for samples screened with cobas CT/NG
10.1128/jcm.01039-23 · 2024
Single-sample confirmation of positive Gonorrhea and Chlamydia results using the Roche Cobas CT/NG and cepheid Xpert CT/NG assays
10.1093/jalm/jfaf120 · 2025
Evaluation of the ResistancePlus MG FleXible cartridge for near-point-of-care testing of Mycoplasma genitalium and associated macrolide resistance mutations
10.1128/jcm.01897-19 · 2020
2025 review of public health laboratory network Australia Neisseria gonorrhoeae national nucleic acid amplification testing guidelines
10.33321/cdi.2025.49.067 · 2025
No additional external references are available.